WELL-MPN: A Digital Lifestyle App for Patients With MPNs
This study is looking at whether a digital app called WELL-MPN can help adults with myeloproliferative neoplasms (MPNs), which are a group of blood cancers. The app aims to improve diet, physical activity, symptoms, emotional well-being, and overall quality of life. Researchers want to see if people with MPNs can use the app effectively and if it leads to better lifestyle habits and fewer symptoms compared to receiving written educational materials. The study plans to enroll about 75 participants. To join, you must be at least 18 years old, have an MPN diagnosis, and be able to speak and understand English. The study's success will be measured by how many people use the app and complete its modules, and by participant satisfaction scores.
- Study design
- This is an interventional study that will compare participants using the WELL-MPN digital app with those receiving written educational materials. It plans to enroll about 75 adult participants.
- What's involved
- Participants randomized to the WELL-MPN arm will be given access to the WELL-MPN digital program (app) which provides lifestyle counseling through an iPad. The study measures satisfaction scores from enrollment to 16 weeks after enrollment.
- Compensation
- Not stated in the trial record.
- Follow-up
- The study measures participant satisfaction up to 16 weeks after enrollment, and app module completion up to 2 years.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
WELL-MPN: A Digital Lifestyle App for Patients With MPNs
At a glance
Conditions
Where it's being run
1 sites across 1 statesStudy leadership
- Chi-Joan How · PRINCIPAL_INVESTIGATOR · Massachusetts General Hospital
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- Number of patients consented and enrolled onto the study, and number of patients who complete at least 2 out of 3 modules in the app.2 years
Primary outcome is feasibility, defined as ≥60% enrollment of eligible patients and ≥70% of patients randomized to the intervention group completing at least 2 out of 3 of app modules.
- 8-Item Client Satisfaction Scores (CSQ-8)Enrollment to 16 weeks after enrollment
Acceptability of WELL-MPN as measured by CSQ-8 scores of WELL-MPN. The CSQ-8 is a self-report tool designed to measure patient satisfaction with a received intervention. It consists of 8 items rated on a 4-point Likert scale (from "quite dissatisfied" to "very satisfied"), with higher scores indicating greater satisfaction. WELL-MPN is considered acceptable if \>80% of participants on the WELL-MPN arm report a CSQ-8 score \>20.